ISSN 2149-2263 | E-ISSN 2149-2271 Home      
Volume : 19 Issue : 2
Current Issue Archive Popular Article Ahead of Print

Quick Search

Anatol J Cardiol: 19 (2)
Volume: 19  Issue: 2 - February 2018
Hide Abstracts | << Back
1.New Term
Çetin Erol
PMID: 29424750  doi: 10.14744/AnatolJCardiol.2018.2  Page 85
Abstract | Full Text PDF

2.Lack of association of tumor necrosis factor superfamily member 4 (TNFSF4) gene polymorphisms (rs3850641 and rs17568) with coronary heart disease and stroke: A systematic review and meta-analysis
Jin- Sen Lu, Hong Wang, Fei- Fei Yuan, Le- Le Wu, Bin Wang, Dong- Qing Ye
PMID: 29424751  doi: 10.14744/AnatolJCardiol.2017.8069  Pages 86 - 93
Objective: To evaluate the association between the tumor necrosis factor superfamily member 4 (TNFSF4) gene polymorphisms and common cardiovascular and cerebrovascular diseases.
Method: A literature-based search was operated through database including PubMed, EMBASE, Cochrane Library, CNKI and WanFang data. Crude odds ratios (ORs) and 95% confidence intervals (CI) were calculated to estimate the strength of the association between TNFSF4 polymorphisms (rs3850641 and rs17568) and the risk of coronary heart disease and stroke.
Results: 11 eligible studies were included in this meta-analysis. It was showed that G allele was not associated with CHD and stroke, compared with A allele (rs3850641: OR 1.02, 95%CI.: 0.89, 1.17; rs17568: OR 1.09, 95%CI.: 0.89, 1.33). Genotypic analysis demonstrated that there was no significantly association between the risk of CHD and stroke and rs3850641 (homozygous comparison (GG vs. AA): OR 1.05, 95%CI.: 0.74, 1.50; heterozygous comparison (GA vs. AA): OR 1.00, 95%CI.: 0.88, 1.13; recessive model (GG vs. GA + AA): OR 1.04, 95%CI.: 0.76, 1.43; dominant model (GG + GA vs. AA): OR 1.01, 95%CI.: 0.88, 1.17). Similarly, no susceptibility between CHD and stroke and rs17568 polymorphism was uncovered (GG vs. AA: OR 1.04, 95%CI.: 0.74, 1.46; GA vs. AA: OR 1.07, 95%CI.: 0.62, 1.83; GG + GA vs. AA: OR 1.13, 95%CI.: 0.82, 1.56; GG vs. GA + AA: OR 1.01, 95%CI.: 0.74-1.39).
Conclusions: The present study demonstrated that there is no significant relationship between TNFSF4 gene polymorphism and cerebrovascular and cardiovascular diseases.

3.Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart
Mahvash Hesari, Dareuosh Shackebaei, Atefeh Asadmobini
PMID: 29350208  doi: 10.14744/AnatolJCardiol.2017.8038  Pages 94 - 99
Objective: Doxorubicin (DOX) induces cardiac dysfunction. Paracetamol (APAP) has also been established as an effective cardioprotective agent during ischemia/reperfusion. Therefore, this study aims to evaluate the effect of APAP on DOX-induced cardiotoxicity in ischemia/reperfused isolated rat heart.
Methods: A total of 36 rats were equally divided into four groups: control, DOX (30 min, 20 µM DOX perfusion), APAP (15 min before and after ischemia, 0.35 mM APAP perfusion), and DOX+APAP (perfused with the same protocol in DOX and APAP groups). The isolated hearts were perfused according to the Langendorff method. Cardiac parameters, including left ventricular developed pressure (LVDP), heart rate (HR), coronary flow (CF), and rate pressure product (RPP; LVDP×HR) were measured. Lactate dehydrogenase (LDH) concentration was also assessed.
Results: At the end of the baseline period, the RPP, HR, and CF values were lower in the DOX group than in the control group (p<0.01). Meanwhile, there were no significant differences between the values of cardiac function parameters in the DOX+APAP and control groups. In the reperfusion period, the RPP and CF values were significantly increased in the DOX+APAP group compared with the DOX group (p<0.05). Furthermore, the LDH concentration was decreased in the DOX+APAP group compared with the DOX group.
Conclusion: APAP perfusion protected the hearts against DOX-induced cardiotoxicity in the baseline and ischemia/reperfusion conditions. These findings can be explained by the effect of APAP on antioxidant capacity and mitochondrial permeability transition pores.

4.Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study
Evgeny Shkolnik, Greta Burneikaite, Jelena Celutkiene, Mikhail Scherbak, Gitana Zuoziene, Birute Petrauskiene, Ekaterina Trush, Aleksandras Laucevicius, Yury Vasyuk
PMID: 29424731  doi: 10.14744/AnatolJCardiol.2017.8023  Pages 100 - 109
Objective: Despite revascularization and optimal medical treatment (OMT), patients with angina often have a reduced quality of life due to inadequate relief from symptoms. Recent studies have shown that the application of shock waves may reduce angina symptoms and improve quality of life, exercise capacity, and myocardial perfusion due to the stimulation of angiogenesis. However, there is limited evidence due to small, single-arm, single-center studies of low to moderate quality. The purpose of this study is to evaluate the impact of cardiac shock wave therapy (CSWT) on exercise tolerance and angina symptoms in patients with coronary artery disease and objective evidence of myocardial ischemia who cannot undergo traditional revascularization and experience angina despite OMT in comparison to sham procedure.
Methods: We designed a randomized, triple-blind, placebo-controlled, multicentre trial (NCT02339454) to assess the efficacy of CSWT in addition to OMT in patients with stable angina and myocardial ischemia documented by exercise treadmill test (ETT). All patients were treated with stable doses of standard medical treatment 4 weeks before screening. An increase in the total exercise duration on ETT by ≥90 s from the baseline at the end of the study was set as the primary endpoint. Secondary endpoints included angina class, Seattle angina questionnaire scores, symptoms, and ECG changes during stress test. Patients underwent nine sessions of CSWT or corresponding sham procedure applied to all segments of the left ventricle, within 9 weeks. Endpoint assessments were performed at 6-month follow-up. The imaging substudies assessed the potential of CSWT to reduce stress-induced myocardial ischemia detected by dobutamine stress echocardiography, cardiac single-photon emission computed tomography, and cardiac magnetic resonance imaging.
Results: At two centers, 72 of the 323 screened patients were randomized in two groups (ratio 1: 1): active treatment and placebo control. Study patients were predominantly males (70.8%); the mean age of the patients was 68.4±8.3 years. Of these, 44 patients had angina Canadian Cardiovascular Society class III, and 66.7% of the patients had a history of myocardial infarction.
Conclusion: Using sham applicators, blinding study participants, investigators, and endpoints assessors to the study data as well as centralized randomization ensures rigorous methodology and low risk of bias in this large randomized controlled CSWT study.

5.Association of serum prolidase activity in patients with isolated coronary artery ectasia
Erdal Aktürk, Lütfü Aşkın, Hüseyin Nacar, M. Hakan Taşolar, Serdar Türkmen, Mustafa Çetin, Mehmet Bozkurt
PMID: 29339675  doi: 10.14744/AnatolJCardiol.2017.8160  Pages 110 - 116
Objective: Coronary artery ectasia (CAE) is defined as an angiographic enlargement of a portion of the coronary artery between 1.5 and 2 times the diameter of the adjacent normal coronary artery. It has been demonstrated that increased serum prolidase activity (SPA) is associated with increased collagen turnover. We aimed to analyze the relationship between CAE and serum SPA levels.
Methods: This study used a prospective case protocol design. A total of 40 consecutive patients with isolated right CAE and normal coronary arteries (23 men, 17 women; mean age, 62.4±10.8 years) were evaluated. The control group included the same number of consecutive patients with angiographically normal coronary arteries (20 men, 20 women; mean age, 63.8±11.1 years). Clinical characteristics, laboratory results, cardiovascular risk factors, and medication use were recorded. SPA was measured using a spectrophotometer. Student’s t-test, Mann–Whitney U test, chi-square test, Pearson’s and Spearman’s correlations, logistic regression analysis, and ROC curve analysis were used for statistical analysis.
Results: SPA was significantly higher in the CAE group compared with the control group (1635.2±492.0 U/L and 986.2±422.3 U/L, respectively; p<0.001). The relationship of SPA with CAE proved to be significant (r=0.512; p<0.001). SPA also served as an independent predictor of CAE (OR=1.003; 95% CI, 1.001–1.005; p=0.002). The SPA value of 1170 U/L was predictive of CAE, with a sensitivity of 85% and specificity of 60% (AUC=0.854; 95% CI, 0.763–0.944; p<0.001).
Conclusion: The activity of this enzyme was significantly correlated with CAE.

6.Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
Özlem Yayar, Barış Eser, Harun Kılıç
PMID: 29339674  doi: 10.14744/AnatolJCardiol.2017.8019  Pages 117 - 122
Objective: In hemodialysis (HD) patients, cardiovascular disease (CVD) is the major cause of mortality and morbidity. In atherosclerotic diseases, iron gets accumulated in the arterial wall. Hepcidin is an important hormone in iron metabolism. Furthermore, hepcidin is associated with atherosclerotic disease. Therefore, this study aims to investigate the relation of serum hepcidin-25 (SH-25) and sub-clinic atherosclerosis measured by carotid intima-media thickness (CIMT) and mortality in HD patients.
Methods: We enrolled 82 HD patients in a cross-control study. We measured SH-25 using ELISA kit and CIMT using high-resolution real-time ultrasonography. After 4 years of first assessment, we investigated the relation between all-cause and cardiovascular mortality and SH-25 and CIMT.
Results: Two patients were excluded because of renal transplantation. The survivors were younger (53.7±15.1 vs. 65.2±15.5; p<0.05) and CIMT was lower (0.83±0.2 vs. 0.95±0.2; p<0.05); however, there was no significant difference in SH-25 levels between the groups (29.1±13 vs. 32.4±22.4;p=0.767). The patients who died of CVD were significantly older (63.7±16.1 vs. 53.7±15.1; p<0.05) and had significantly higher CIMT (0.94±0.2 vs. 83±0.2; p<0.05). The SH-25 levels were statistically significantly higher in patients who died of CVD (40.3±25 vs. 29.1±13; p<0.05). Linear regression
analysis showed a positive correlation between CIMT and SH-25 in the study population and in those who died from CVD (r=0.41; p<0.05 and r=0.606; p<0.05, respectively).
Conclusion: This study suggests that hepcidin is effective in cardiovascular mortality and pathophysiology of subclinical atherosclerosis in HD patients.

7.Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
Zhong- Ling Zhuo, Hai- Peng Xian, Yan Long, Chang Liu, Yuan- Yuan Sun, Yin- Ting Ma, Hua Gao, Jing- Zhong Zhao, Xiao- Tao Zhao
PMID: 29350207  doi: 10.14744/AnatolJCardiol.2017.8097  Pages 123 - 129
Objective: To investigate the association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance (CR) in patients with cardiovascular disease in Beijing district.
Methods: In total, 325 patients were enrolled in the study, including 101 experimental group patients and 224 control group patients. The experimental group was divided into CR group (n=30) and non-CR group (n=71) according to the adenosine diphosphate (ADP)-induced platelet inhibition rate in thromboelastography (TEG) (ADP-induced platelet inhibition rate of <30% was defined as CR and rate of 30%–100% was defined as non-CR). Genotypes, including CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*17, and ABCB1, were determined using time-of-flight mass spectrometry (Clin-TOF) and Sanger sequencing in all patients.
Results: In the experimental group, carriers of CYP2C19 heterozygous (*1/*2, n=46; *1/*3, n=7), and mutation homozygous (*2/*2, n=7; *2/*3, n=3; *3/*3, n=0) genotypes showed significantly lower ADP-induced platelet inhibition rates than noncarriers (*1/*1, n=38; p=0.035 and 0.001, respectively); the carriage of mutant CYP2C19*2 or *3 allele was significantly associated with an increased risk of CR. In contrast, carriers of ABCB1 heterozygous (TC, n=50) showed significantly lower ADP-induced platelet inhibition rates than noncarriers (CC, n=39, p=0.097), and there was no significant correlation between ABCB1 genotypes and higher CR risk.
Conclusion: The carriage of CYP2C19*2 or *3 mutant allele was significantly associated with attenuated platelet response to clopidogrel and increased CR risk. The carriage of ABCB1 mutant allele was not significantly associated with CR risk.

8.Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
Bin Wang, Jin- Sen Lu, Zhi- Hui Wang, Hong Wang
PMID: 29424732  doi: 10.14744/AnatolJCardiol.2017.27020  Page 130
Abstract | Full Text PDF

9.Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
Nilgün Çekin, Arzu Özcan, Sabahattin Göksel, Serdal Arslan, Ergün Pınarbaşı, Öcal Berkan
PMID: 29424733  doi: 10.14744/AnatolJCardiol.2017.8081  Pages 131 - 136
Objective: Cardiovascular diseases are the most important cause of mortality worldwide, particularly atherosclerosis. Recently, lncRNAs affecting atherosclerotic progression have been reported in vascular smooth muscle cells, endothelial cells, and monocytes, suggesting that lncRNAs play an important role in atherosclerosis.
Methods: In recent clinical studies, nowadays, it was determined that internal mammary bypass grafts are closest to ideal grafts in coronary artery bypass surgery. In this study, we used tissue samples taken from atherosclerotic coronary arteries and the internal mammary artery (IMA) during coronary artery bypass surgery. Using RT-PCR, we investigated the role of two lncRNAs, FENDRR and LincRNA-p21, by comparing their expression levels in coronary artery plaques and normal mammary arteries of 20 atherosclerotic patients.
Results: We found that the FENDRR and LincRNA-p21 expressions decreased by approximately 2 and 7 fold in coronary artery plaques, respectively, compared with those in IMA, which is known to have no plaque development.
Conclusion: This study was the first to use mammary artery tissues of the same patients as a control and to study FENDRR expression. Our data may provide helpful insights regarding the association of lncRNAs and atherosclerosis.

10.What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias
Emin Evren Özcan, Bülent Görenek
PMID: 29424734  doi: 10.14744/AnatolJCardiol.2017.8223  Pages 137 - 139
Although various cardiac monitoring methods were developed to detect subclinical arrhythmias, guidelines do not address in detail the management of subclinical atrial fibrillation and tachyarrhythmias. The European Heart Rhythm Association recently published a consensus document that addresses the clinical importance, implications, and management of device-detected subclinical atrial tachyarrhythmias. This paper comprehensively reviews the diagnostic tools to detect subclinical atrial arrhythmias and discusses the pathophysiologic link between device-detected subclinical atrial fibrillation and stroke. In this invited review, in the light of this paper and current scientific data, we aimed to summarize how to manage subclinical atrial arrhythmias.

11.MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers?
Zhongxiu Chen, Chen Li, Ke Lin, Qing Zhang, Yucheng Chen, Li Rao
PMID: 29424735  doi: 10.14744/AnatolJCardiol.2017.8124  Pages 140 - 147
Traditional circulating biomarkers play a fundamental role in the diagnosis and prognosis of acute myocardial infarction (AMI). However, they have several limitations. microRNAs (miRs), a class of RNA molecules that do not encode proteins, function directly at the RNA level by inhibiting the translation of messenger RNAs. Due to their significant roles in disease development, they can be used as biomarkers. Accumulating evidence has revealed an attractive role of miRs as biomarkers of AMI and its associated symptoms, including vulnerable atherosclerotic plaques, and their role in disease diagnosis, platelet activation monitoring, and prognostic outcome prediction. This manuscript will highlight the recent updates regarding the involvement of miRs as biomarkers in AMI and emphasize their value in vulnerable atherosclerotic plaque prediction and monitoring of platelet activation.

12.Management of scar-related atrial flutter in a patient with dextrocardia, inferior vena cava interruption, and azygos continuation
Veysel Kutay Vurgun, Başar Candemir, Ali Timuçin Altın, Ömer Akyürek
PMID: 29424736  doi: 10.14744/AnatolJCardiol.2017.7950  Pages 148 - 149
Abstract | Full Text PDF

13.Catheter ablation of manifest posteroseptal accessory pathway associated with coronary sinus diverticula in a child with congenitally corrected transposition of the great arteries
Yakup Ergül, Osman Esen, Senem Özgür, Alper Güzeltaş
PMID: 29424737  doi: 10.14744/AnatolJCardiol.2017.8108  Pages 149 - 151
Abstract | Full Text PDF

14.Lead extraction: Definition standards
Serkan Çay, Fırat Özcan, Özcan Özeke
PMID: 29424738  doi: 10.14744/AnatolJCardiol.2017.8210  Page 152
Abstract | Full Text PDF

15.Author`s Reply
Antonis S. Manolis, Georgios Georgiopoulos, Sofia Metaxa, Spyridon Koulouris, Dimitris Tsiachris
PMID: 29424739  Pages 152 - 153
Abstract | Full Text PDF

16.Lead extraction and contrast venography
Fatih Mehmet Uçar
PMID: 29424740  doi: 10.14744/AnatolJCardiol.2017.8211  Pages 153 - 154
Abstract | Full Text PDF

17.Author`s Reply
Antonis S. Manolis, Georgios Georgiopoulos, Sofia Metaxa, Spyridon Koulouris, Dimitris Tsiachris
PMID: 29424741  Page 154
Abstract | Full Text PDF

18.Contrast-induced acute kidney injury/contrast-induced nephropathy may be related to additional risk factors
Hilmi Umut Ünal, Yalçın Başaran, Hadim Akoğlu
PMID: 29424742  doi: 10.14744/AnatolJCardiol.2017.66915  Page 155
Abstract | Full Text PDF

19.Author`s Reply
Veysel Oktay, Ilknur Çalpar Çıralı, Ümit Yaşar Sinan, Ahmet Yıldız, Murat Kazım Ersanlı
PMID: 29424743  Pages 155 - 156
Abstract | Full Text PDF

20.An unusual complication during reimplantation of implantable cardioverter defibrillator (ICD) after ICD leads extraction: Distal migration of anchoring sleeve
Ahmet Korkmaz, Havva Tuğba Gürsoy, Bekir Demirtaş, Özgül Uçar Elalmış, Ümit Güray
PMID: 29424744  doi: 10.14744/AnatolJCardiol.2017.8249  Pages 156 - 157
Abstract | Full Text PDF

21.Ten years’ clinical experience of cardiac myxoma: diagnosis, treatment, and clinical outcomes
Hidayet Kayançiçek, Emjed Khalil, Gökhan Keskin, Özkan Alataş, Erhan Hafız, Ömer Faruk Doğan
PMID: 29424745  doi: 10.14744/AnatolJCardiol.2017.8265  Pages 157 - 158
Abstract | Full Text PDF

22.Sudden cardiac death in physicians: an alarming problem in China
Xinmiao Shi, Rui Liu
PMID: 29424746  doi: 10.14744/AnatolJCardiol.2017.8263  Page 158
Abstract | Full Text PDF

23.Functional paraganglioma in the right atrium
Jingxiu Fan, Zhong Wu, Yan Kang
PMID: 29424747  doi: 10.14744/AnatolJCardiol.2017.8241  Page E2
Abstract | Full Text PDF

24.Spontaneous giant pseudoaneurysm in the upper segment of the aortic arch
Qian He, Hong- Yu Jin, Ji- Wen Geng
PMID: 29424748  doi: 10.14744/AnatolJCardiol.2017.8267  Pages E2 - E3
Abstract | Full Text PDF

25.An unusual cause of aortic regurgitation: accessory mitral valve
Mete Han Kızılkaya, Fahrettin Uysal, Özlem Mehtap Bostan, Volkan Yazıcıoğlu
PMID: 29424749  doi: 10.14744/AnatolJCardiol.2017.8275  Pages E3 - E4
Abstract | Full Text PDF | Video

KARE Publishing | Copyright © 2018 Turkish Society of Cardiology